These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2758728)

  • 1. Zidovudine disposition in patients with severe renal impairment: influence of hemodialysis.
    Singlas E; Pioger JC; Taburet AM; Colin JN; Fillastre JP
    Clin Pharmacol Ther; 1989 Aug; 46(2):190-7. PubMed ID: 2758728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics of zidovudine (AZT) and its metabolite (G-AZT) in healthy subjects and in patients with kidney failure].
    Pioger JC; Taburet AM; Colin JN; Colaneri S; Fillastre JP; Singlas E
    Therapie; 1989; 44(6):401-4. PubMed ID: 2623653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats.
    Mays DC; Dixon KF; Balboa A; Pawluk LJ; Bauer MR; Nawoot S; Gerber N
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1261-70. PubMed ID: 1762074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of zidovudine in patients with liver cirrhosis.
    Taburet AM; Naveau S; Zorza G; Colin JN; Delfraissy JF; Chaput JC; Singlas E
    Clin Pharmacol Ther; 1990 Jun; 47(6):731-9. PubMed ID: 2357867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of hemodialysis on zidovudine (AZT) and its glucuronide (GAZT) pharmacokinetics: two case reports.
    Garraffo R; Cassuto-Viguier E; Barillon J; Chanalet L; Lapalus P; Duplay H
    Int J Clin Pharmacol Ther Toxicol; 1989 Nov; 27(11):535-9. PubMed ID: 2613387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of azidothymidine and its major metabolite glucuronylazidothymidine in hemophiliacs coinfected with human immunodeficiency virus and chronic hepatitis C.
    Rockstroh JK; Reichel C; Hille H; Oldenburg J; Brackmann HH
    Am J Ther; 1998 Nov; 5(6):387-91. PubMed ID: 10099082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of drug interactions with anti-human immunotrophic virus (HIV) Drugs. III. 2',3'-Dideoxycytidine (ddC) and zidovudine in monkeys.
    Qian MX; Swagler AR; Mehta M; Vishwanathan CT; Gallo JM
    Pharm Res; 1992 Feb; 9(2):224-7. PubMed ID: 1313173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.
    Gallo JM; Finco TS; Swagler AR; Mehta MU; Viswanathan CT; Qian M
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):277-83. PubMed ID: 1540413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probenecid inhibits the metabolic and renal clearances of zidovudine (AZT) in human volunteers.
    Hedaya MA; Elmquist WF; Sawchuk RJ
    Pharm Res; 1990 Apr; 7(4):411-7. PubMed ID: 2362917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis.
    Kremer D; Munar MY; Kohlhepp SJ; Swan SK; Stinnett EA; Gilbert DN; Young EW; Bennett WM
    Pharmacotherapy; 1992; 12(1):56-60. PubMed ID: 1549540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of zidovudine in HIV-infected patients with end-stage renal disease.
    Kimmel PL; Lew SQ; Umana WO; Li PP; Gordon AM; Straw J
    Blood Purif; 1995; 13(6):340-6. PubMed ID: 8821198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys.
    Cretton EM; Schinazi RF; McClure HM; Anderson DC; Sommadossi JP
    Antimicrob Agents Chemother; 1991 May; 35(5):801-7. PubMed ID: 1854160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of standard breakfast on pharmacokinetics of oral zidovudine in patients with AIDS.
    Ruhnke M; Bauer FE; Seifert M; Trautmann M; Hille H; Koeppe P
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2153-8. PubMed ID: 8257138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of drug interactions with anti-human immunodeficiency virus drugs. VI. Effect of the calcium channel blocker nimodipine on zidovudine kinetics in monkeys.
    Gallo JM; Swagler AR; Mehta M; Qian M
    J Pharmacol Exp Ther; 1993 Jan; 264(1):315-20. PubMed ID: 8423534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of zidovudine pharmacokinetics by probenecid in patients with AIDS or AIDS-related complex.
    de Miranda P; Good SS; Yarchoan R; Thomas RV; Blum MR; Myers CE; Broder S
    Clin Pharmacol Ther; 1989 Nov; 46(5):494-500. PubMed ID: 2582706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine removal during plasma exchange.
    Fauvelle F; Leon A; Petitjean O; Guillevin L
    J Clin Apher; 1991; 6(3):155-7. PubMed ID: 1787132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of interaction between zidovudine and 4-methyl-amino-antipyrine, the active metabolite of metamizole, in human liver in vitro.
    Bacracheva N; Kamali F
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):299-301. PubMed ID: 8830197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.
    Boase S; Miners JO
    Br J Clin Pharmacol; 2002 Nov; 54(5):493-503. PubMed ID: 12445028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucuronidation of 3'-azido-3'-deoxythymidine (zidovudine) by human liver microsomes: relevance to clinical pharmacokinetic interactions with atovaquone, fluconazole, methadone, and valproic acid.
    Trapnell CB; Klecker RW; Jamis-Dow C; Collins JM
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1592-6. PubMed ID: 9660989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairment.
    Leroy A; Fillastre JP; Borsa-Lebas F; Etienne I; Humbert G
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2794-8. PubMed ID: 1482147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.